References
- Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra
L, et al., Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head
and Neck. N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi:
10.1056/NEJMoa1602252. Epub 2016 Oct 8. PMID: 27718784; PMCID:
PMC5564292.
- Arina A, Gutiontov SI, Weichselbaum RR. Radiotherapy and Immunotherapy
for Cancer: From ”Systemic” to ”Multisite”. Clin Cancer Res. 2020 Jun
15;26(12):2777-2782. doi: 10.1158/1078-0432.CCR-19-2034. Epub 2020 Feb
11. PMID: 32047000.
- Daguenet E, Louati S, Wozny AS, Vial N, Gras M, Guy JB, et al.,
Radiation-induced bystander and abscopal effects: important lessons
from preclinical models. Br J Cancer. 2020 Aug;123(3):339-348. doi:
10.1038/s41416-020-0942-3. Epub 2020 Jun 25. PMID: 32581341; PMCID:
PMC7403362.
- Parikh AR, Szabolcs A, Allen JN, Clark JW, Wo JY, Raabe M, et al.,
Radiation therapy enhances immunotherapy response in microsatellite
stable colorectal and pancreatic adenocarcinoma in a phase II trial.
Nat Cancer. 2021 Nov;2(11):1124-1135. doi: 10.1038/s43018-021-00269-7.
Epub 2021 Nov 18. PMID: 35122060; PMCID: PMC8809884.
- Qian JM, Schoenfeld JD. Radiotherapy and Immunotherapy for Head and
Neck Cancer: Current Evidence and Challenges. Front Oncol. 2021 Feb
3;10:608772. doi: 10.3389/fonc.2020.608772. PMID: 33614492; PMCID:
PMC7886974.
- McBride S, Sherman E, Tsai CJ, Baxi S, Aghalar J, Eng J, et al.,
Randomized Phase II Trial of Nivolumab With Stereotactic Body
Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck
Squamous Cell Carcinoma. J Clin Oncol. 2021 Jan 1;39(1):30-37. doi:
10.1200/JCO.20.00290. Epub 2020 Aug 21. PMID: 32822275; PMCID:
PMC8462641.
- Leidner R, Crittenden M, Young K, Xiao H, Wu Y, Couey MA, et al.,
Neoadjuvant immunoradiotherapy results in high rate of complete
pathological response and clinical to pathological downstaging in
locally advanced head and neck squamous cell carcinoma. J Immunother
Cancer. 2021 May;9(5):e002485. doi: 10.1136/jitc-2021-002485. PMID:
33963014; PMCID: PMC8108690.
- Botticelli A, Mezi S, Pomati G, Sciattella P, Cerbelli B, Roberto M,
et al., The Impact of Locoregional Treatment on Response to Nivolumab
in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial.
Vaccines (Basel). 2020 Apr 20;8(2):191. doi: 10.3390/vaccines8020191.
PMID: 32326034; PMCID: PMC7349768.